News & Events about Verrica Pharmaceuticals Inc.
Registration Stability Batch for VP-102 Completed and Placed on Stability Process Validation Batches Successfully Manufactured Verrica Reaffirms its Expected Q1 2023 NDA Resubmission for VP-102 WEST CHESTER, Pa., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Verrica) (Nasdaq: VRCA...
Ticker Report
2 months ago
Verrica Pharmaceuticals (NASDAQ:VRCA Get Rating) and Lexicon Pharmaceuticals (NASDAQ:LXRX Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, risk, ...
Verrica Pharmaceuticals (NASDAQ:VRCA Get Rating) and Lexicon Pharmaceuticals (NASDAQ:LXRX Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, ...
VRCA SHAREHOLDER ALERT: Jakubowitz Law Reminds Verrica Shareholders of a Lead Plaintiff Deadline of August 5, 2022 VRCA SHAREHOLDER ALERT: Jakubowitz Law Reminds Verrica Shareholders of a Lead Plaintiff Deadline of August 5, 2022 PR Newswire NEW YORK, Aug. 5, 2022 NEW YORK, Aug. 5, 2022...
FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm PR Newswire LOS...